Sera Prognostics (SERA) Change in Account Payables (2020 - 2026)
Sera Prognostics (SERA) posted Change in Account Payables of -$70000.0 for Q1 2026, up 25.53% on a QoQ basis from -$94000.0 in Q4 2025, and up 92.97% year-over-year from -$36274.7 in Q1 2025.
Sera Prognostics (SERA) Change in Account Payables (2020 - 2026) Analysis & Trends
Sera Prognostics' Change in Account Payables history runs 7 years deep, the most recent figure standing at -$70000.0 for Q1 2026.
- Quarterly Change in Account Payables rose 92.97% year-over-year to -$70000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$83000.0 (up 83.85% YoY) and the FY2025 annual result came in at -$1.0 million, down 321.76% from the prior year.
- Change in Account Payables was -$70000.0 for Q1 2026 at Sera Prognostics, up from -$94000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $556000.0 in Q4 2022 and bottomed at -$996000.0 in Q1 2025.
- A 5-year average of -$42000.0 and a median of -$15000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 554.12% — and 2025, when it tumbled 3588.89%.
- Sera Prognostics' Change in Account Payables stood at $556000.0 in 2022, then tumbled by 132.37% to -$180000.0 in 2023, then surged by 312.22% to $382000.0 in 2024, then plunged by 124.61% to -$94000.0 in 2025, then increased by 25.53% to -$70000.0 in 2026.
- Business Quant data shows SERA's Change in Account Payables at -$70000.0 in Q1 2026, -$94000.0 in Q4 2025, and $52000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | - |
| 10 | Sera Prognostics | 104.54 Mn | 104.54 Mn | -28,000.00 | -70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70,000.00 |
| Mar 31, 2026 | -70,000.00 |
| Dec 31, 2025 | -94,000.00 |
| Dec 31, 2025 | -94,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | -996,000.00 |
| Mar 31, 2025 | -996,000.00 |
| Dec 31, 2024 | 382,000.00 |
| Dec 31, 2024 | 382,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -27,000.00 |
| Mar 31, 2024 | -27,000.00 |
| Dec 31, 2023 | -180,000.00 |
| Dec 31, 2023 | -180,000.00 |